These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9157125)

  • 1. Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem.
    Daly JS; Dodge RA; Glew RH; Soja DT; DeLuca BA; Hebert S
    J Clin Microbiol; 1997 Apr; 35(4):1027-9. PubMed ID: 9157125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenem.
    Cooper GL; Louie A; Baltch AL; Chu RC; Smith RP; Ritz WJ; Michelsen P
    J Clin Microbiol; 1993 Sep; 31(9):2366-70. PubMed ID: 8408557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to meropenem.
    Atmaca S
    J Med Microbiol; 1998 Jul; 47(7):653. PubMed ID: 9839571
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients.
    Ballestero S; Fernández-Rodríguez A; Villaverde R; Escobar H; Pérez-Díaz JC; Baquero F
    J Antimicrob Chemother; 1996 Jul; 38(1):39-45. PubMed ID: 8858455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to imipenem in Pseudomonas aeruginosa.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):1037-41. PubMed ID: 8821603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.
    Muramatsu H; Horii T; Morita M; Hashimoto H; Kanno T; Maekawa M
    Int J Med Microbiol; 2003 Jun; 293(2-3):191-7. PubMed ID: 12868655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.
    Cambau E; Perani E; Dib C; Petinon C; Trias J; Jarlier V
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2248-52. PubMed ID: 8619577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital].
    Kakeya H; Yamada K; Nakaie K; Takizawa E; Okada Y; Fujita A; Nakamura Y; Abe J; Hirose A; Kaneko Y; Hino M
    Jpn J Antibiot; 2014 Aug; 67(4):241-8. PubMed ID: 25420320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
    Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of various technics in the determination of sensitivity of Pseudomonas aeruginosa to imipenem].
    Maugein J; Fourche J; Pellegrin JL; Mormède M
    Pathol Biol (Paris); 1990 May; 38(5):362-5. PubMed ID: 2114605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of quality control measures to prevent reporting of false resistance to imipenem, resulting in a pseudo-outbreak of imipenem-resistant Pseudomonas aeruginosa.
    Carmeli Y; Eichelberger K; Soja D; Dakos J; Venkataraman L; DeGirolami P; Samore M
    J Clin Microbiol; 1998 Feb; 36(2):595-7. PubMed ID: 9466787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP; Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C.
    Turgeon PL; Desrochers C
    Antimicrob Agents Chemother; 1985 Nov; 28(5):711-2. PubMed ID: 3867331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray.
    Staneck JL
    J Clin Microbiol; 1986 Jun; 23(6):1134-5. PubMed ID: 3086377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
    Chin NX; Neu HC
    Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
    Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.
    Piddock LJ; Turner HL
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1186-91. PubMed ID: 1291320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and killing effect of DX-8739, a new carbapenem, compared with those of meropenem and imipenem against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    Antimicrob Agents Chemother; 1995 Mar; 39(3):731-4. PubMed ID: 7793881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.